| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novocure Limited (NVCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. NVCR is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 437.6K | $6.00M | - | |
| Dir | 416.5K | $5.71M | - | |
| VP | 347.7K | $4.77M | - | |
| Other | 174.5K | $2.39M | - | |
| Other | 163.8K | $2.25M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Cordova Ashley75 | Chief Executive Officer | Sell | 13,494 | $19.72 | $266,126.29 | -2.1% | +1.7% | -28.4% | |
| Feb 27, 2025 | Leupin Nicolas | Chief Medical Officer | Sell | 991 | $20.02 | $19,843.57 | -1.0% | +0.7% | -29.0% | |
| Feb 27, 2025 | Puri Michal Nath | Chief Human Resources Officer | Sell | 1,387 | $20.02 | $27,772.77 | -0.6% | +0.7% | -29.0% | |
| Jan 11, 2025 | Paravasthu Mukund69 | Chief Operating Officer | Sell | 2,160 | $26.81 | $57,906.14 | -6.4% | -39.9% | -48.3% | |
| Nov 2, 2024 | Paravasthu Mukund69 | Chief Operating Officer | Sell | 44 | $16.69 | $734.18 | -1.3% | +51.5% | -24.4% | |
| Nov 1, 2024 | Leonard Frank X76 | EVP, Pres., Novocure Oncology | Sell | 598 | $15.94 | $9,530.74 | -0.4% | +57.7% | -20.8% | |
| Nov 1, 2024 | Paravasthu Mukund69 | Chief Operating Officer | Sell | 160 | $15.88 | $2,540.42 | -4.4% | +57.7% | -20.8% | |
| Oct 31, 2024 | Puri Michal Nath | Chief Human Resources Officer | Sell | 810 | $15.79 | $12,791.68 | -0.7% | +68.1% | -15.6% | |
| Aug 2, 2024 | Cordova Ashley75 | Chief Financial Officer | Sell | 688 | $20.14 | $13,857.42 | -0.3% | -26.7% | -45.3% | |
| Jun 4, 2024 | Scannell Timothy J | Director | Sell | 964 | $23.89 | $23,027.45 | -24.5% | -26.6% | -26.7% |